Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Compare tax exposure between dividend ETFs and taxable funds in 2024 to identify the lower-tax option for your goals.
28,172 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Imagine a personal AI assistant that lives on your phone, watches, listens, and taps inside apps without ever sending...
A pivotal AI funding milestone shifts how investors view tech giants. Learn what the Anthropic move signals for Amazo...
As a month-long unlock window approaches, investors face how liquidity shifts can impact SpaceX stock swings. This gu...
When a wedding invite becomes news, boundaries matter. This article analyzes the simone biles sharpest answer and sho...
A 변화 in baby-name trends goes beyond taste. These baby names actually reveal how culture, language, and practical pla...
As 2026 unfolds, a $1,000 split between XRP and SOL tests volatility, regulatory clarity, and upgrade momentum. This ...
Apple introduces its most affordable devices to date, with price points starting at $599. The move targets price-cons...
Meta Platforms faced a $119 billion market-cap drop as regulators threaten stricter data, privacy and ad rules. Analy...
A widowed 85-year-old is at the center of a rapid debate over lending to seniors as major banks pursue high-rate cred...
Bitcoin's struggle to reclaim the $69,000 holder level could reset the short-term trend, with XRP eyeing a potential ...
Bitcoin holds a key floor as bulls defend $60k while bears press higher targets. The market pauses with potential for...